September 24, 2018 | FAH Policy Blog Team
Category: Financing, Pharmaceuticals, Quality
This afternoon FAH filed comments with CMS regarding the 2019 Hospital Outpatient Prospective Payment System (OPPS) proposed rule.
September 11, 2018 | FAH Policy Team
Category: Financing, Health Care Delivery
The Federation of American Hospitals (FAH) submitted comments late today on CMS’ Physician Fee Schedule proposed rule.
In a letter to CMS Administrator Seem Verma, FAH wrote, “It is imperative that providers focus on the care and well-being of their patients without unnecessary regulatory burden getting in the way…we appreciate CMS identifying a number of areas where policies can be updated, and burden reduced. However, we do have significant concerns with a number of CMS’s proposed policies including the proposal to collapse the payment rates for E/M visit codes.”
August 21, 2018 | FAH Policy Blog Team
Category: FAH News, Legislation, Pharmaceuticals
Rising and excessive drug prices threaten patient access to the drugs they need and can undermine the care physicians see as necessary for patients. The Grassley-Durbin amendment (#3787) would take a great leap forward in providing consumers useful information on drug prices that could help them buy smart. And, the public display of prices could put a spotlight on those high prices and bring them down.
August 20, 2018 | FAH Policy Blog Team
Category: FAH News
FAH and its company leaders are strongly represented on the just released 2018 “100 Most Influential People in Healthcare” list from Modern Healthcare. The annual ranking is a collaboration between the magazine’s senior editors and readers. After a nomination process, readers pick their favorites from a preliminary ballot of 300. The final rankings take into account vote totals and input from the senior editors.